Bullish option flow detected in Seres Therapeutics with 3,842 calls trading, 2.0x expected, and implied vol increasing almost 2 points to 103.03%. May-23 5 calls and May-23 7.5 calls are the most active options, with total volume in those strikes near 2,000 contracts. The Put/Call Ratio is 0.10. Earnings are expected on May 10th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MCRB:
- Seres Therapeutics price target lowered to $10 from $12 at Chardan
- Seres Therapeutics, Nestle Health Science gets FDA approval of VOWSTTM
- Seres Therapeutics initiated with a Neutral at JPMorgan
- Seres Therapeutics price target raised to $15 from $11 at Canaccord
- Seres Therapeutics price target lowered to $11 from $17 at Canaccord